Network pharmacology combined with bioinformatics to investigate the mechanism of Xianlinggubao capsule in the treatment of osteoporosis
Background: Xianlinggubao capsule (XLGB), a traditional Chinese medicine (TCM) prescription, has been widely applied to treat osteoporosis (OP) in China. However, its active components and mechanism have not been fully elucidated. Purpose: This study aims to elucidate the active components of XLGB a...
Saved in:
Main Authors: | Yuyun Li (Author), Rang Li (Author), Zhanwei Zeng (Author), Siyan Li (Author), Shiyi Liao (Author), Wenhui Ma (Author), Chenhui Zhou (Author), Daohua Xu (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Deciphering the underlying mechanism of Xianlinggubao capsule against osteoporosis by network pharmacology
by: Hangsheng Bao, et al.
Published: (2020) -
Serum Pharmacochemistry Analysis Combined with Network Pharmacology Approach to Investigate the Antiosteoporosis Effect of Xianlinggubao Capsule in vivo
by: Yun-Hui Xu, et al.
Published: (2020) -
Kaempferol Ameliorates the Inhibitory Activity of Dexamethasone in the Osteogenesis of MC3T3-E1 Cells by JNK and p38-MAPK Pathways
by: Baocheng Xie, et al.
Published: (2021) -
XianLingGuBao protects against osteoporosis through activating STAT3 in vitro and vivo
by: Zhihua Li, et al.
Published: (2024) -
Evaluation of Biological Mechanisms of Quanduzhong Capsule for Treating Osteoporosis by Integrating Untargeted Metabolomics and Network Pharmacology
by: Fang-Fang Yu, et al.
Published: (2023)